Researchers described results as 'an important first step' in potentially developing new treatment for people with advanced cancers.
Vous n'êtes pas connecté
WEDNESDAY, Sept. 4, 2024 -- Current vaccines against mpox were designed to fight an older, rarer cousin of the virus, smallpox.Now, new research from the drug company Moderna suggests its new mpox vaccine, based on mRNA technology, might do a...
Researchers described results as 'an important first step' in potentially developing new treatment for people with advanced cancers.
Cancer vaccine shows promise A new cancer vaccine, mRNA-4359, developed by Moderna, could revolutionise cancer treatment. This vaccine is designed...
An experimental mRNA cancer vaccine shows promising results in a Phase 1 trial, potentially offering new hope for advanced-stage cancer patients.
TORONTO - Health Canada has authorized Moderna's updated COVID-19 vaccine that protects against currently circulating variants of the virus. The mRNA...
TORONTO - Health Canada has authorized Moderna's updated COVID-19 vaccine that protects against currently circulating variants of the virus. The mRNA...
TORONTO — Health Canada authorized Moderna's updated COVID-19 vaccine that protects against currently circulating variants of the virus on Tuesday....
TORONTO — Health Canada authorized Moderna's updated COVID-19 vaccine that protects against currently circulating variants of the virus on Tuesday....
TORONTO — Health Canada has authorized Moderna's updated COVID-19 vaccine that protects against currently circulating variants of the virus. The...
TORONTO — Health Canada has authorized Moderna's updated COVID-19 vaccine that protects against currently circulating variants of the virus.
Researchers from Thomas Jefferson University and the University of Maryland Baltimore, in collaboration with the United States Army Medical Research...